Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
The company will initially develop a vaccine to tackle colorectal and pancreatic cancers
Read More
Tag: oncology
Corcept Therapeutics’ relacorilant plus nab-paclitaxel shows positive results in ovarian cancer
Ovarian cancer is the fifth leading cause of deaths from cancer in women
Read More
ErVimmune raises 17m euros in funding to develop cancer vaccine
The vaccine could be created as a ready-to-use product, rather than needing to be personalised
Read More
MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
MRM’s platform could optimise the link between the gut microbiome and cancer outcomes
Read More
NHS rolls out new initiative to identify pancreatic cancer earlier
The pilot will see GP practices look at patient records to identify those most at risk
Read More
Teva and Fosun Pharma partner on early-stage oncology drug
The candidate is being evaluated as both a monotherapy and in combination pembrolizumab
Read More
Lumanity and Parker Institute partner to support delivery of new immunotherapies
The alliance combines Lumanity’s commercial and development strategy capabilities with PICI’s translational research expertise
Read More
Lab-grown lung cancer cells show potential to revolutionise treatment
The model could lead to more targeted treatments for the disease
Read More
Valneva Scotland announces year-long support for local cancer charity Team Jak
The company’s workforce will volunteer and fundraise for Team Jak throughout the year
Read More
myTomorrows and Pancreatic Cancer Europe partner on clinical trials
The partnership will improve care for patients with pancreatic cancer
Read More
National campaign launches to end prostate cancer postcode lottery
Over 135,000 people have signed a petition to prioritise a national screening programme
Read More
MHRA approves Astellas’ Vyloy combination for gastric cancer
Most cases go undetected until an advanced stage, as the disease rarely causes early symptoms
Read More
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
